NCT02000622 2026-02-13
OlympiAD
AstraZeneca
Phase 3 Completed
Clinical Trials
4 trialsNCT00707707 2018-03-06
Phase I/II Study of AZD2281 Given in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer
AstraZeneca
Phase 1 Completed
NCT00710268 2015-01-14
Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours
AstraZeneca
Phase 1 Completed
NCT00633269 2009-01-14
Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours
AstraZeneca
Phase 1 Completed